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Abstract
Nitric oxide (NO) is important in the regulation of renal tubular function. We have investigated whether glycated proteins
could impair the NO production by examining the effects of Amadori products (AP-BSA) and advanced glycation end
products (AGE-BSA) on primary cultures of rabbit proximal tubular epithelial (PTE) cells. Nitric oxide synthase activity was
assessed by measurement of the conversion of L-arginine to L-citrulline and by production of NO, after short-term (30 min)
or long-term (1 or 3 days) incubation. Short incubations of PTE cells with either 200 Wg/ml AP-BSA or 40 Wg/ml AGE-BSA
significantly decreased NO production. AP-BSA (3000 Wg/ml) inhibited the Ca2-dependent NOS activity even though above
50 Wg/ml it increased Ca2-independent NOS activity. In contrast, 40 Wg/ml AGE-BSA inhibited both isoforms of NOS.
Longer incubations with 200 Wg/ml AP-BSA or 250 Wg/ml AGE-BSA decreased NO release and inhibited Ca2-dependent
and -independent NOS activities. APs did not affect NO release by S-nitroso-N-acetyl-penicillamine (SNAP), while 250 Wg/
ml AGEs decreased it. After 3 days incubation, glycation products had no effect on the NOS cell content. Cell viability and
proliferation were not modified under these experimental conditions, suggesting that the fall in NO production was not due
to there being fewer cells. These data indicate that APs and AGEs directly inhibit NOS activity, and additionally that AGEs
quench released NO. Thus, both types of glycated proteins alter the production of NO by PTE cells and could participate in
the renal tubule dysfunction associated with aging and diabetes. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The glycation of plasma and tissue proteins is in-
volved in the development of the nephropathy that
occurs with normal aging and progresses more rap-
idly in diabetes [1^4]. Glucose reacts non-enzymati-
cally with the primary amino groups of proteins to
form early glycated residues called Amadori products
(APs). Those APs on long-lived proteins can undergo
a complex series of reactions to produce stable cova-
lent adducts called advanced glycation end products
(AGEs). The increase of APs in plasma [5,6] and the
accumulation of AGEs in renal tissues [7,8] have
recently been linked with the complications that oc-
cur with aging and with renal failure. Despite the
close relationship between the degree of tubulointer-
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stitial ¢brosis and the decline in the glomerular ¢l-
tration rate, indicating that the lesions of the kidney
involve non-glomerular as well as glomerular struc-
tures [9,10], most studies have focused exclusively on
glomerulosclerosis as the cause of age-related nephr-
opathy [11]. Although the predominant form of cir-
culating glycated proteins in vivo are APs [5,12,13],
macrophage degradation products of AGEs accumu-
lated on matrix proteins are released into the circu-
lation as AGE-peptides to be cleared by the kidney.
Indeed, the amount of AGE-peptide in the serum is
correlated with renal function [14^16]. However,
AGE-peptides have been found to be cleared more
slowly than creatinine, indicating that signi¢cant
AGE reabsorption occurs in the proximal convoluted
tubule [17]. Other studies have referred to the pref-
erential transit of APs through the glomerular ¢ltra-
tion barrier [5,18,19] followed by an enhanced up-
take by epithelial cells [20,21]. Glycated proteins
could be reabsorbed at least partly via a receptor-
mediated mechanism, since receptors for both APs
and AGEs are found on several cell types, including
tubular epithelial cells [22,23]. Activation of these
receptors may trigger several cell responses, such as
cytokine secretion and oxidation-enhancing reac-
tions, particularly nitric oxide (NO) production
[21,24,25]. NO production is mediated by the activity
of NO synthase (NOS), a family of at least three
di¡erent isoforms: the constitutive calcium/calmodu-
lin (Ca2/CaM)-dependent neuronal and endothelial
form (cNOS) and the inducible Ca2-independent
macrophage form (iNOS). A variety of cells and tis-
sues, especially renal tubular epithelial cells, possess
both constitutive endothelial (ecNOS) [26,27] and in-
ducible (iNOS) NO synthase [28]. NO at low levels is
an important intracellular messenger involved in the
regulation of renal hemodynamic and renal tubular
functions [29]. NO even functions as an autocrine
hormone in some cell types [30,31].
As the proximal tubular epithelial (PTE) cells are
bathed in primitive urine containing a high concen-
tration of both types of glycated proteins, these dam-
aged proteins could a¡ect the NO-related regulation
of the renal tubular function during aging and dia-
betes. We have therefore examined the e¡ect of glyc-
ated proteins on the activity of both Ca2/CaM-de-
pendent and -independent NOS using primary
cultures of rabbit PTE cells.
2. Materials and methods
2.1. Proximal tubular epithelial cell culture
Primary cultures of renal proximal tubules were
prepared according to Blais et al. [32]. Adult New
Zealand white rabbits (male, 1.5 kg, Charles River,
St. Aubin les Elbeuf, France) were anesthetized with
i.p. pentobarbital (3 mg/100 g body weight). The
kidneys were removed aseptically, placed in 30 ml
ice-cold Hank’s bu¡er and decapsulated. All subse-
quent steps were performed under sterile conditions.
The medulla was dissected out and the pieces of cor-
tex were placed in 50 ml ice-cold Hank’s bu¡er (Sig-
ma Chemicals, St. Louis, MO), washed until the
supernatant was clear, and suspended in Hank’s/
DMEM/HAMF12 (1:1, Sigma) solution containing
0.125% (w/v) collagenase A (Boehringer Mannheim,
Mannheim, Germany), 0.1% (w/v) hyaluronidase
(Sigma) and 0.25% (w/v) BSA free fatty acid (FFA)
(Sigma) at 37‡C in 95% O2/5% CO2, and gently shak-
en for 40 min. The resulting digest was ¢ltered
through a tea-strainer, washed with 50 ml of Hank’s
and centrifuged (600Ug, 4 min). The pellet was
washed three times, suspended in a ice-cold Hank’s
solution containing 0.5% (w/v) BSA FFA, and kept
on ice for 10 min. This suspension was centrifuged
(600Ug, 4 min) and the resulting pellet was mixed
with 60 ml ice-cold Percoll 42% (v/v) (Amersham
Pharmacia Biotech, Uppsala, Sweden) in Krebs^
Henseleit bu¡er (KHB), divided into two 30-ml frac-
tions and centrifuged (32 000Ug, 30 min) without the
brake, for the separation of tubules fragments as
described by Vinay et al. [33]. The fourth band con-
taining over 98% of the proximal tubular fragment
was carefully removed and washed three times in
DMEM/HAMF12 (1:1). The tubules were suspended
in 45 ml DMEM/HAMF12 supplemented with bo-
vine insulin (0.5 Wg/ml, Sigma), human transferrin
(17.5 Wg/ml, Sigma), ethanolamine (20 WM, Sigma),
T3 (5 nM, Sigma), dexamethasone (Dex) (0.1 WM,
Sigma) and fetal calf serum (FCS) (1%, Institut
Jacques Boy, Reims, France).
Culture £asks (75 cm2, Costar, Cambridge, MA)
were coated with collagen type I (Sigma) before the
tubules were transferred in them. The cultures were
maintained at 37‡C in a humidi¢ed 95% O2/5% CO2
air incubator. Unattached tubules were removed 24 h
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later by aspiration and fresh medium was added
without FCS. Thereafter, the culture medium was
changed every 3 days. Con£uent cells were obtained
after 6^7 days and each preparation underwent one
passage only in a 25-cm2 £ask or 6- or 24-well plates
(Costar) coated with collagen type I. Such culture
conditions allowed selective growth of PTC. Since
PTC maintained di¡erentiated properties for up to
2 weeks [32], all cultures were used within 2 weeks.
Five days before use, PTE cells were grown without
phenol red or dexamethasone, as phenol red can in-
terfere with the Griess reagent [34] while Dex inhibits
iNOS especially in epithelial cells [35].
2.2. Enzyme assays
The purity of each preparation was assessed imme-
diately after the isolation of proximal tubules by
light microscopy, and only preparations that were
s 90% tubules were used. Con£uent cells were trypsi-
nized and disrupted, then their protein content was
assayed (Bradford method). Solutions of 0.5 mg/ml
protein in Tris-bu¡ered saline (TBS; 40 mM Tris^
HCl, 300 mM NaCl, pH 7.5) were used to measure
alkaline phosphatase (31.13 þ 6.5 Wmol/Pi per min)
activity and Na,K-ATPase (14.89 þ 4.59 Wmol/Pi
per min) activity. The results were consistent with
published data [36]. Each determination was per-
formed in triplicate.
2.3. Preparation and characterization of glycation
proteins
AP-BSA and AGE-BSA were prepared according
to Makita et al. [37]. Brie£y BSA (50 mg/ml) was
incubated with 0.5 M glucose in 0.2 M phosphate
bu¡er (pH 7.4) containing protease inhibitors for
5 days (AP) or 60 days (AGE). All incubations
were performed under sterile conditions at 37‡C
and in the dark. After incubation, unbound glucose
was removed by extensive dialysis against phosphate-
bu¡ered saline (PBS). While AP-BSA was puri¢ed by
the phenyl-boronate a⁄nity column (Glyco-Gel B
from Pierce) [23], native albumin was removed
from AGE-BSA preparation using the a⁄nity chro-
matography on A⁄-Gel Blue; the AGEs were then
reduced with 100 mM sodium borohydride (Sigma),
dialyzed against PBS and characterized as previously
described [8]. In these oxidation conditions, AGEs
are largely glycoxidation products [38].
As we have previously shown [5], AP-BSA con-
tains 2^3 mol glucose/mol albumin. To check if the
glucose albumin might have an e¡ect on the NO
production by the PTE cells, we incubated these cells
with a 15^750 nM range of glucose which corre-
sponds approximately with amount of sugar linked
to 50^3000 Wg/ml of AP-BSA.
2.4. Assessment of cell viability and proliferation
PTE cells were incubated for 72 h either alone,
with BSA (50^3000 Wg/ml, Sigma), AP-BSA (50^
3000 Wg/ml), or AGE-BSA (5^2000 Wg/ml). After-
wards, cells were subjected to trypsinization, col-
lected by centrifugation, resuspended in medium
and stained with 0.3% trypan blue for 5 min. The
number of viable cells was determined by counting in
duplicate the trypan blue negative cells in a hemocy-
tometer using an inverse phase-contrast microscope.
In each case, at least 200 cells were counted. Data
were plotted as a percentage of viable cells relative to
the total number cells plated.
On the other hand, cells were seeded at 2U104
cells/ml in 24-well plates and subcon£uent cultures
incubated for 24 h with 3 ml serum-free medium to
synchronize them at the G0 stage. The cells were then
incubated for 24 h with 1 ml medium containing the
indicated concentration of AGE-BSA, AP-BSA,
SNAP or BSA and [3H]thymidine (1 WCi/ml, ICN)
for 24 h. [3H]Thymidine incorporation was stopped
by placing the plates on melting ice and washing with
PBS (3U5 min), methanol/acetic acid (4:1) (1U15
min), 80% methanol (1U10 min), 5% trichloroacetic
acid (3U5 min) and absolute ethanol (2U5 min).
The plates were dried (30 min, 37‡C) and cells were
lysed by incubation with 750 Wl EDTA (10 mM, pH
12.4) for 2 h at 37‡C. The lysates were neutralized
and aliquots (10 Wl) were counted (Tri-Carb 2100 T;
Packard Instrument Company) to determine
[3H]thymidine incorporation.
2.5. Measurement of NO release
Cultures of con£uent proximal tubule cells were
incubated for 30 min at 37‡C with N-nitro-L-arginine
methyl ester (L-NAME) (0.2^5 mM, Sigma), BSA
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(50^3000 Wg/ml), glucose (15^750 nM), AP-BSA (50^
3000 Wg/ml), or AGE-BSA (5^2000 Wg/ml). Some cell
cultures were incubated with BSA, AP-BSA or AGE-
BSA for 24 or 72 h without medium shift. The me-
dium (4 ml) was then removed from each £ask and
the cells were harvested and homogenized in 1 ml of
PBS. Acellular in vitro studies were performed by
incubation of AP-BSA or AGE-BSA plus 1 mM S-
nitroso-N-acetyl-penicillamine (SNAP; Calbiochem^
Novabiochem, La Jolla, CA) in 4 ml of PBS in glass
hemolysis tubes, for 30 min at 37‡C. This concentra-
tion of SNAP was chosen to empirically generate the
amount of NO produced by the cultured PTE cells;
indeed, cell culture produced 13 WM NO/30 min and
1 mM SNAP used in vitro generated 56.5 WM NO/30
min.
The NO released from epithelial cells or produced
in vitro in the presence of glycation products was
assayed by measuring nitrite (NO32 ) and nitrate
(NO33 ) (stable breakdown products of NO) in the
culture medium or the cell-free incubates, using the
Griess reaction [34]. NO measured in the medium in
the presence of increasing concentrations of BSA,
AP-BSA or AGE-BSA is equivalent to the NO con-
centration in the control (12.39 þ 0.42 WM NO), so
incubated proteins did not interfere with the subse-
quent Griess reaction. Our ¢ndings on NO produc-
tion by the PTE cells were in agreement with other
studies performed on proximal tubules [39]. Brie£y,
210-Wl aliquots of conditioned medium from each
£ask were placed in glass hemolysis tubes containing
5 Wl NADPH (250 WM, Sigma) and 5 Wl nitrate re-
ductase (60 mU, Sigma). The mixture was incubated
for 30 min at 37‡C; 5 Wl L-glutamate dehydrogenase
(200 mU, Sigma), 15 Wl NH4Cl (100 mM, Sigma) and
10 Wl K-ketoglutarate (4 mM, Sigma) were then
added and incubation was continued for a further
20 min at 37‡C. Lastly, 250 Wl Griess reagent (1%
sulfanilamide in 5% HCl 1.2 N and 0.1% N-(1-naph-
thyl)ethylenediamine dihydrochloride (1:1)) was
added at room temperature and the tubes were in-
cubated in the dark for 30 min. Aliquots (100 Wl) of
the resulting magenta chromophore were placed in
the wells of 96-well plates and the absorbances at
540 nm were immediately measured in a microplate
reader (MR 700, Dynatech Laboratories, Alexandria,
VA). The NO concentrations were read o¡ from a
standard curve produced by adding known amounts
of sodium nitrite to the medium.
2.6. Assessment of nitric oxide synthase activity
We assessed both Ca2-dependent and functional-
ly Ca2-independent NOS activities in PTE cells by
measuring the conversion of L-[14C]arginine to L-
[14C]citrulline [39,40]. Levels of L-[14C]citrulline pro-
duced were similar to those recorded in other studies
performed on PTE cells [27] and the production of
NO evaluated by the Griess reaction was equimolar
to the production of L-citrulline from L-arginine as
reported previously [41]. Con£uent PTE cells plated
in 6-well plates (Costar) were treated for 30 min with
either BSA (3000 Wg/ml), AP-BSA (50 Wg/ml, 3000
Wg/ml), AGE-BSA (40 Wg/ml, 2000 Wg/ml), EGTA
(2 mM), Ca2 ionophore A-23187 (Sigma) in the
presence of Ca2 (2 mM), or AP-BSA or AGE-
BSA in the presence of A-23187 and Ca2. Other
plates were incubated for 72 h with the same concen-
trations of BSA, AP-BSA and AGE-BSA and also
with lipopolysaccharide (LPS; 10 Wg/ml) to di¡eren-
tially induce the iNOS expression, in the presence or
absence of 1 WM Dex, AP-BSA or AGE-BSA. Cells
were washed three times with TBS and scraped o¡
with a rubber policeman. After centrifugation
(1000Ug, 5 min, 4‡C), cell pellets were reconstituted
in 0.5 ml of cold homogenizing bu¡er (50 mM Tris^
HCl, pH 7.5) containing 1 mM EDTA, 10 Wg/ml
leupeptin, 10 Wg/ml aprotinin, 10 Wg/ml pepstatin A
and sonicated on ice for 1 min. The homogenate was
then centrifuged (15 000Ug, 45 min, 4‡C) and the
supernatant was passed through a Dowex AG50W-
X8 column (Na form, 100^200 mesh) to remove
endogenous L-arginine. Protein content was deter-
mined using the Bradford protein assay. To deter-
mine the activity of the Ca2-dependent NOS, each
sample (400 Wl) was incubated with bu¡er A (50 mM
Tris^HCl, pH 7.7) containing the cofactors (¢nal
concentration: 0.5 WM calmodulin, 2 mM NADPH,
1 mM DTT, 10 WM FAD, 10 WM FMN, 10 WM
tetrahydrobiopterin, 1.25 mM CaCl2, 50 mM L-va-
line, to inhibit arginase) and substrate 1 WCi/ml L-
[14C]arginine (speci¢c activity 300 mCi/mmol, ICN,
Costa Mesa, CA). The Ca2-independent NOS activ-
ity was measured by incubating samples (400 Wl) in
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bu¡er A, from which CaCl2 and calmodulin had
been omitted and replaced by EGTA (1 mM).
The reaction was carried out at 37‡C for 45 min
and ended by adding 2 ml of stop solution contain-
ing 20 mM sodium acetate (pH 5.5), 2 mM EDTA
and 2 mM EGTA. 1.5 ml of the mixture was passed
over a 1-ml Dowex AG50W-X8 column (Na form)
and L-[14C]citrulline was eluted with an additional
2 ml of water. Citrulline formation and the speci¢c
activity of L-[14C]arginine were quanti¢ed using liq-
uid scintillation counting (Tri-Carb 2100 T; Packard
Instrument Co., Meriden, CT). Each determination
was assayed in duplicate and results are expressed as
nmol of L-[14C]citrulline produced per mg of protein
for 30 min or 72 h.
2.7. Western blot analysis
Cellular levels of iNOS or cNOS protein were es-
timated by immunoblotting. Brie£y, PTE cells were
grown in a 25-cm2 £ask (Costar). The cells were ex-
posed to BSA (3000 Wg/ml), AP-BSA (3000 Wg/ml),
AGE-BSA (2000 Wg/ml) and LPS (10 Wg/ml) for 72 h.
Then, the cells were washed twice in ice-cold PBS,
scraped and centrifuged (1000Ug, 5 min, 4‡C). Pel-
lets were sonicated on ice for 1 min in 20 mM Hepes
(pH 7.5) containing 2 mM EDTA, 2 mM EGTA,
10 Wg/ml leupeptin, 5 Wg/ml aprotinin and 1 mM
PMSF, and then centrifuged (16 000Ug, 30 min,
4‡C). The protein content of the supernatant was
determined using the Bradford protein assay (Bio-
Rad) and used for western blotting analysis.
Twenty-¢ve Wg of protein was used for the ecNOS
analysis, and 200 Wg for the inducible NOS (iNOS)
and neuronal NOS (bNOS). Proteins were boiled for
10 min and sodium dodecyl sulfate^polyacrylamide
gel electrophoresis (SDS^PAGE) was performed on
10% gels using the Laemmli bu¡er system [42]. Pro-
teins were transferred to nitrocellulose (Hybond-C,
Amersham) and blots were blocked overnight at
4‡C in TBS (pH 7.5) containing 5% non-fat dried
milk. All subsequent steps were performed at room
temperature. Blots were rinsed twice for 5 min with
TBS containing 0.05% Tween-20 and then incubated
for 1 h in TBS with either anti-murine iNOS IgG
(1:2500 dilution, Transduction Laboratories, Lexing-
ton, KY) or anti-rabbit ecNOS IgG (1:1000 dilution,
Transduction Laboratories) for 1 h in TBS. Blots
were then washed four times (5 min each) in TBS
containing 0.05% Tween-20, and incubated for 1 h
with either horseradish peroxidase-conjugated sheep
polyclonal anti-mouse IgG antibody (1:5000 dilu-
tion, Amersham) or goat polyclonal anti-rabbit IgG
antibody (1:5000 dilution, Sigma). Blots were
washed ¢ve times (5 min each) with TBS containing
0.05% Tween-20 and incubated with ECL reagents
(Amersham) before exposure for at least 3 min to
Hyper ¢lm enhanced chemiluminescence (Amer-
Table 1
E¡ect of glycated products on Ca2-dependent- and Ca2-independent NOS activity after short-term incubation with PTE cells
[14C]Citrulline (nmol/mg protein)
Ca2-Dependent NOS Ca2-Independent NOS
Control 0.359 þ 0.008 0.478 þ 0.008
BSA (3000 Wg/ml) 0.431 þ 0.013** 0.583 þ 0.031**
AP-BSA (50 Wg/ml) 0.376 þ 0.014 0.586 þ 0.013**
AP-BSA (3000 Wg/ml) 0.260 þ 0.021* 0.617 þ 0.028**
AGE-BSA (40 Wg/ml) 0.302 þ 0.009** 0.418 þ 0.009**
AGE-BSA (2000 Wg/ml) 0.175 þ 0.011*** 0.299 þ 0.022***
A23187+CaCl2 1.620 þ 0.240** 0.640 þ 0.093
AP-BSA (50 Wg/ml)+A23187+CaCl2 1.545 þ 0.208 0.580 þ 0.060
AP-BSA (3000 Wg/ml)+A23187+CaCl2 0.700 þ 0.01622 0.525 þ 0.016
AGE-BSA (40 Wg/ml)+A23187+CaCl2 1.384 þ 0.036 0.577 þ 0.017
AGE-BSA (2000 Wg/ml)+A23187+CaCl2 0.972 þ 0.0392 0.503 þ 0.018
EGTA (2 mM) 0.236 þ 0.002*** ND
Cells were incubated with either BSA, AP-BSA, AGE-BSA or EGTA for 30 min, or pre-stimulated with glycated products (10 min)
and incubated subsequently with calcium ionophore A-23187 (2 WM) and CaCl2 (2 mM) for 30 min. *P6 0.05, **P6 0.01,
***P6 0.001 vs. control untreated cells ; 2P6 0.05, 22P6 0.01 vs. Ca2-stimulated cells.
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sham). Film autoradiograms were analyzed and
quanti¢ed by scanning (JX-330, Sharp Corp., Japan)
and computer-assisted densitometry (Image Master
1D, Pharmacia-Biotech, Sweden).
2.8. Statistical analysis
Data are expressed as mean þ S.E.M. Results were
compared by analysis of variance followed by the
Student t-test for unpaired data. A value of
P6 0.05 was considered statistically signi¢cant.
3. Results
Primary cultures of rabbit PTE cells were used to
assess the e¡ect of glycated proteins on NOS activ-
ities. To this end, we assayed the formation of L-
citrulline from L-arginine in cell lysates and the NO
production in the culture medium after cell exposure
for a short time with Ca2 ionophore or long-time
stimulation with LPS, to discriminate between the
activities of Ca2-dependent and -independent NOS.
3.1. E¡ect of AP-BSA or AGE-BSA on
NO production
We ¢rst veri¢ed that incubation of free-cell culture
medium with increasing concentrations of AP- or
AGE-BSA does not interfere with the subsequent
Griess reaction for the determination of NO release.
A short incubation (30 min) of PTE cells with 200
Wg/ml (and more) AP-BSA produced a signi¢cant
decrease of NO level in the culture medium
(P6 0.05) (Fig. 1A). Incubation with AGE-BSA
gave a similar dose-dependent e¡ect with concentra-
tions of 40 Wg/ml and above (P6 0.05) (Fig. 1B). To
determine whether nitrite production was completely
NOS-dependent, we brie£y (30 min) incubated PTE
cells with increasing concentrations of L-NAME, a
speci¢c inhibitor of both types of NOS. Cells incu-
bated for 30 min with 2 mM and 5 mM L-NAME
produced signi¢cantly less NO in the medium, re-
spectively 0.22 þ 0.01 (P6 0.01) and 0.16 þ 0.01
nmol/mg protein (P6 0.001) than the control cells,
0.38 þ 0.03 nmol/mg protein.
SNAP, an exogenous donor of NO in vitro, was
used to test whether glycated proteins inhibited the
NOS activity or caused chemical inactivation of NO.
APs (50^3000 Wg/ml) had no e¡ect on NO release by
1 mM SNAP (Fig. 2A), whereas AGEs (above
250 Wg/ml) decreased the NO level in the medium
(P6 0.05) (Fig. 2B).
To determine whether both glycation products
have a short and transitory inhibitory e¡ect on the
NO metabolism, we incubated PTE cells with in-
creasing concentrations of APs and AGEs for a pro-
longed incubation (1 or 3 days). APs above 200 Wg/
ml (Fig. 3A) and AGEs above 250 Wg/ml (Fig. 3B),
produced a dose-dependent decrease in NO produc-
tion in the culture medium (P6 0.05 and P6 0.01,
respectively).
Fig. 1. Dose-dependent inhibition of nitrite production by short
incubation (30 min) of AP-BSA or AGE-BSA with rabbit PTE
cells. Cells were incubated with various concentrations of AP-
BSA, BSA or glucose (A), or AGE-BSA (B). Nitrite production
is expressed in nmol/mg of protein. Values are the mean þ
S.E.M. of six independent experiments. *P6 0.05, **P6 0.01
vs. control untreated cells. AGE-BSA, advanced glycation end
products of bovine serum albumin; AP-BSA, Amadori product
of bovine serum albumin; PTE, proximal tubular epithelial.
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3.2. E¡ect of glycated proteins on NOS activities
PTE cells were treated with calcium ionophore A-
23187 and NOS activity was measured in the lysates
as production of L-[14C]citrulline. After 30 min incu-
bation with BSA, cells exhibited an increase in both
Ca2-dependent and -independent NOS basal activ-
ities in comparison with controls (P6 0.01) (Table
1). With 3000 Wg/ml AP-BSA, the Ca2-dependent
NOS activity was lower than with control cells
(P6 0.05), whereas the e¡ect on Ca2-independent
NOS activity was the opposite (P6 0.01). Incubation
with 40 Wg/ml (and above) AGE-BSA produced an
inhibitory e¡ect on both NOS activities. When PTE
cells were treated with the calcium ionophore in the
presence of CaCl2, these cells exhibited a higher
Ca2-dependent NOS activity than control
(P6 0.01) while pretreatment of these cells with
3000 Wg/ml AP- or 2000 Wg/ml AGE-BSA led to a
drop in this activity (P6 0.01 and P6 0.05,
respectively). No signi¢cant e¡ect was observed on
Ca2-independent NOS activity under these condi-
tions.
Incubation of PTE cells for 72 h with 3000 Wg/ml
AP- or 2000 Wg/ml AGE-BSA (Table 2) decreased
both the Ca2-dependent and -independent NOS ac-
tivities (P6 0.05). To test the speci¢c iNOS activity
in PTE cells, L-[14C]citrulline production was eval-
uated after cells treatment with 10 Wg/ml LPS; these
cells exhibited only an increased Ca2-independent
NOS activity (P6 0.05). Preincubation of these
LPS-treated cells with 1 WM Dex led to a decrease
Fig. 3. Dose-dependent inhibition of nitrite production during
prolonged incubation (1 or 3 days) of AP-BSA or AGE-BSA
with rabbit PTE cells. Cells were incubated with various con-
centrations of AP-BSA, BSA (A) or AGE-BSA (B). Nitrite pro-
duction is expressed in nmol/mg of protein. Values are the
mean þ S.E.M. of four independent experiments. *P6 0.05,
**P6 0.01, ***P6 0.001 vs. control untreated cells.
Fig. 2. E¡ect of increased concentrations of AP-BSA (A) and
AGE-BSA (B) on the nitric oxide (NO) released by SNAP (1
mM) in a cell-free system. SNAP was incubated for 30 min
with various concentrations of AP-BSA or AGE-BSA. Control
production in medium was 56.5 þ 5.2 WM NO32 . Data are ex-
pressed as amount of NO quenched. Values are the mean þ
S.E.M. of three independent experiments. *P6 0.05, **P6 0.01
vs. control. SNAP, S-nitroso-N-acetyl-penicillamine.
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in that Ca2-independent activity (P6 0.01). Both
high concentrations of AP- and AGE-BSA tended
to lower the NOS activities, but only the e¡ect of
AGE (3000 Wg/ml) was signi¢cant (P6 0.05). These
results suggest that iNOS activity evidenced in PTE
cells after LPS treatment is Ca2-independent.
3.3. E¡ect of glycated proteins on cellular
NOS content
As shown in Fig. 4A, immunoblots of lysates from
PTE cells incubated for 72 h either with BSA, AP-
BSA, AGE-BSA or LPS contained single bands
stained positively with ecNOS antibody and exhib-
ited the expected ecNOS molecular mass (140 kDa).
Exposure of the cells to high concentration of AP-
BSA (3000 Wg/ml) for 72 h had no e¡ect on the in-
tensity of the ecNOS band, while 2000 Wg/ml AGE-
BSA tended to reduce the staining (P = 0.053). In
addition, LPS (10 Wg/ml) decreased the ecNOS pat-
tern. No pattern of bNOS was revealed by immuno-
blotting (data not shown) suggesting that this iso-
form is not present in PTE cells.
Similarly, immunoblots using anti iNOS antibody
(Fig. 4B), showed a distinct pattern at 130 kDa cor-
responding to the expected molecular size of iNOS.
As before, BSA, AP-BSA and AGE-BSA had no
e¡ect on the intensity of iNOS, in contrast to LPS
which signi¢cantly increased the iNOS content of the
cells (P6 0.05).
Table 2
E¡ect of glycated products on Ca2-dependent- and Ca2-independent NOS activity after long-term incubation with PTE cells
[14C]Citrulline (nmol/mg protein)
Ca2-Dependent NOS Ca2-Independent NOS
Control 0.449 þ 0.028 0.384 þ 0.015
BSA (3000 Wg/ml) 0.447 þ 0.041 0.408 þ 0.028
AP-BSA (50 Wg/ml) 0.403 þ 0.038 0.403 þ 0.042
AP-BSA (3000 Wg/ml) 0.241 þ 0.019** 0.279 þ 0.021**
AGE-BSA (40 Wg/ml) 0.373 þ 0.030 0.427 þ 0.037
AGE-BSA (2000 Wg/ml) 0.237 þ 0.019** 0.312 þ 0.021*
LPS 0.455 þ 0.051 2.276 þ 0.146
Dexamethasone (1 WM)+LPS 0.386 þ 0.044 0.704 þ 0.08722
AP-BSA (50 Wg/ml)+LPS 0.464 þ 0.034 2.342 þ 0.147
AP-BSA (3000 Wg/ml)+LPS 0.403 þ 0.044 1.660 þ 0.198
AGE-BSA (40 Wg/ml)+LPS 0.363 þ 0.063 1.913 þ 0.420
AGE-BSA (2000 Wg/ml)+LPS 0.161 þ 0.0162 0.875 þ 0.0572
Cells were incubated with either BSA, AP-BSA, AGE-BSA or LPS (10 Wg/ml) or with both glycated products and LPS for 72 h.
*P6 0.05, **P6 0.01 vs. control untreated cells ; 2P6 0.05, 22P6 0.01 vs. LPS-stimulated cells.
Table 3
213E¡ect of glycation products on the viability of PTE cells
Protein concentration
(Wg/ml)
Percent viable cells
Control 0 93.24 þ 0.93
50 92.60 þ 1.29
100 90.97 þ 1.55
BSA 200 91.07 þ 1.02
1000 90.85 þ 0.25
3000 91.83 þ 2.18
50 91.26 þ 0.91
50 91.26 þ 0.91
100 91.49 þ 0.79
AP-BSA 200 89.64 þ 1.59
1000 89.68 þ 2.05
3000 90.72 þ 0.40
5 91.55 þ 1.64
5 91.55 þ 1.64
40 90.51 þ 1.58
AGE-BSA 250 90.46 þ 1.62
750 90.48 þ 2.05
2000 89.96 þ 2.09
Cells were incubated with di¡erent concentrations of BSA, AP-
BSA or AGE-BSA, and the proportion of viable cells was de-
termined after 72 h of incubation. Viability was determined by
the trypan blue exclusion test. Data are expressed as mean per-
cent viability þ S.E.M. of four independent experiments. Control
cells counts are 1233 dead cells per 17 825 total cells.
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3.4. E¡ect of glycated proteins on cell viability and
proliferation
Exposure of PTE cells to BSA and AP-BSA (50^
2000 Wg/ml) or AGE-BSA (5^3000 Wg/ml) for 72 h
had no signi¢cant e¡ect on cell viability as deter-
mined by trypan blue exclusion in comparison with
control cells grown in medium alone (Table 3). These
data suggest that the APs and AGEs do not decrease
NO production or NOS activity by inducing cell
death.
In another set of experiments, cell proliferation
was evaluated by measuring [3H]thymidine incorpo-
ration, expressed as nCi/24 h (Fig. 5). Incubation of
PTE cells for 24 h with 1000 Wg/ml APs (Fig. 5A) or
750 Wg/ml AGEs (Fig. 5B) had no detectable e¡ect
on cell proliferation. Cell proliferation was signi¢-
cantly inhibited only by much higher concentrations
of glycated proteins, 3000 Wg/ml APs (P6 0.01) and
2000 Wg/ml AGEs (P6 0.01). These data suggest that
the lowest concentrations of APs and AGEs used
above do not decrease NO production or NOS ac-
tivity by blocking cell proliferation.
Fig. 4. E¡ect of exposure to glycation product on endothelial
cell (ecNOS) and inducible NOS (iNOS) expression in PTE
cells. Cells were incubated with either BSA, AP-BSA, AGE-
BSA or LPS for 72 h. Cell lysates were subjected to 10% SDS^
PAGE and immunoblotted with anti-ecNOS antibody (A) or
anti-iNOS antibody (B). A typical result from three independ-
ent experiments is presented at the top and results obtained by
densitometric analysis are shown at the bottom. Molecular size
markers are shown on the left. Arbitrary units of ecNOS and
iNOS in untreated PTE cells are calculated at 100. Data are
shown as mean þ S.E.M. *P6 0.05 vs. control untreated cells.
LPS, bacterial lipopolysaccharide.
Fig. 5. E¡ect of APs-BSA or AGEs-BSA on the proliferation
of rabbit PTE cells. Cells were incubated for 24 h with APs-
BSA or BSA (A) or AGEs-BSA (B). [3H]Thymidine incorpora-
tion into DNA is expressed as nCi/24 h. Data are expressed as
mean þ S.E.M. of four independent experiments. **P6 0.01,
***P6 0.001 vs. control untreated cells.
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In contrast, incubating cells with SNAP led to sig-
ni¢cant inhibition of proliferation; [3H]thymidine in-
corporation fell from 15.74 þ 0.71 nci/24 h (control)
to 10.02 þ 1.15 (P = 0.01) and 8.03 þ 1.83 nci/24 h
(Ps 0.001) when incubated with 1 mM and 5 mM
SNAP, respectively, indicating the potent cytostatic
e¡ect of NO.
Thus, while both early and advanced glycation
products can rapidly inhibit the Ca2-dependent
NOS activity of PTE cells, only AGEs were able to
inhibit quickly the Ca2-independent NOS activity
and decrease the NO content in the medium by a
quenching process.
4. Discussion
Many studies have shown that APs and AGEs
a¡ect NO or its metabolism [1,43,44]. Highly tuned
regulation of this free radical is crucial, particularly
for the nephron, as it greatly in£uences renal func-
tion [45]. We have shown in this study that early and
late glycated proteins decrease both Ca2-dependent
and -independent NOS activities and NO production
by PTE cells. The cell-free studies showed that incu-
bating APs with SNAP (the in vitro NO donor), led
to no decrease in the NO content in the medium,
whereas AGEs caused a decrease. This decreased
NO production by the PTE cells was not due to an
inhibition of the cell viability or proliferation by
glycated proteins because the incubation of cells
with low concentrations of both glycation products
(200 Wg/ml APs and 40 Wg/ml AGEs) led to a drop of
the NO release without a¡ecting cell viability or cell
proliferation. Nevertheless, the inhibition of PTE cell
proliferation produced by higher concentrations of
APs (2000 Wg/ml) and AGEs (3000 Wg/ml) is in agree-
ment with the typical anti-proliferative e¡ect of APs
and AGEs reported in previous studies performed on
cultured mesangial or osteoblast cells [46,47]. How-
ever, we have found that this e¡ect was not mediated
by NO which is itself a potent PTE cell anti-prolif-
erative factor. This cytostatic e¡ect of NO could be
due to the high concentrations of this free radical
produced during stress by the iNOS, as already dem-
onstrated in other cell types [48,49]. We have also
con¢rmed the presence of both ecNOS and iNOS
at basic level in cultured rabbit PTE cells, in agree-
ment with previous studies [28,50]. Indeed the LPS
and Dex sensitivity of the Ca2-independent NOS
activity demonstrated here is the characteristic of
the iNOS [35,51,52]. The short time needed to de-
crease the Ca2-independent NOS activity observed
in presence of AGEs may be due to the inhibition of
this isoform which generally does not require in-
creased Ca2 levels for activation [50]. Nevertheless,
we cannot exclude the presence of either a cNOS
activity Ca2-independent not yet described or an
iNOS activity Ca2-dependent such as identi¢ed in
other cell types [53,54]. The e¡ect of APs on Ca2-
independent NOS activity seems more complex and
act in two phases. As observed, a short-term incuba-
tion (30 min) led to an increase in Ca2-independent
activity, whereas a long-term incubation (1 day and
above) decreased it. This stimulation of NOS activity
can be joined with a report claiming that cNOS in
macula densa is activated by APs perfused in normal
rat, inducing a glomerular hyper¢ltration [13]. The
fact that the Ca2-dependent activity was stimulated
in response to Ca2 ionophore incubation indicated
that these PTE cells express a cNOS regulated by
transient elevations in intracellular Ca2. In addition,
our study has shown a decrease of that Ca2-depen-
dent NOS activity in these brief Ca2-pre-stimulated
cells obtained by adding high concentrations of both
glycation products. These data are in agreement with
numerous other studies showing that such Ca2-de-
pendent activity due to cNOS, can be quickly modu-
lated by many biological and pharmacological fac-
tors [55^57]. These stimulations induce in turn a
posttranslational modi¢cation of the NOS, presum-
ably phosphorylation, by Akt kinase [58,59]. More-
over, we showed that LPS down regulated the ec-
NOS expression, in accordance with previous
studies [60], suggesting that the Ca2-dependent ac-
tivity we evidenced here was due to ecNOS and that
the nNOS we failed to immunoreveal in PTE cells is
not relevant. Thus, these results suggest that incuba-
tion of PTE cells with APs decreases NO production
by inhibiting ecNOS activity while the quick e¡ect on
iNOS is not clear. AP-mediated modulation of NOS
activities may be due to a transduction signaling
pathway upon binding to the receptor present on
the proximal convoluted tubule cells [23]. In contrast,
AGEs not only act by inhibiting ecNOS and iNOS
activities, but also by quenching the NO released into
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the medium, con¢rming their capacity to reduce the
number of free NO molecules, as shown previously
in vitro [1].
Longer incubation (1 or 3 days) of PTE cells with
APs or AGEs produced similar decreases in NOS
activities and NO release in the medium. This glyc-
ated proteins-mediated inhibition a¡ects both Ca2-
dependent and -independent NOS activities in con-
trol whereas only AGEs act in LPS pre-stimulated
cells. The fact that inhibition of activities is appar-
ently not due to a decrease in amount of NOS sug-
gests a posttranslational process at an early stage,
although we cannot completely exclude the AGEs
inhibition linked to a decrease in the ecNOS content
in PTE cells. Indeed, it has been reported that AGE
products can suppress ecNOS expression in vascular
endothelial cells after 5 days of exposure [43]. More-
over, recent in vivo studies performed on streptozo-
tocin-treated or spontaneously diabetic rats showed a
decrease in the expression of cNOS and iNOS in the
renal cortex [61,62] and a dysregulation of NO me-
tabolism [63,64]. Diabetic and old animals have a
high level of glycation products and an especially
high rate of APs and AGE-peptides in urine, both
inducing renal physiological dysfunction [65]. Those
observations could be closely linked, because APs
and AGEs can induce the accumulation of glomer-
ular extracellular matrix components that leads to
nephron sclerosis [66,67]. It has been hypothesized
that the increased renal production of NO that oc-
curs in some glomerular diseases may switch o¡ the
PKC pathway and reduce the production and accu-
mulation of matrix molecules, thus attenuating the
severity of glomerulosclerosis [44,68]. This down-reg-
ulation of NO production by the PTE cells induced
by APs or AGEs may increase the accumulation of
extracellular matrix components. Recently, it was
shown that the age-related decrease in cNOS tran-
scription in peritubular capillaries was linked to the
appearance of tubulointerstitial ¢brosis [69]. The
lowering of NO concentration due to glycation prod-
ucts may also lead to the alterations in natriuresis
that occur with aging. Indeed, NO tightly controls
both the apical Na/H exchanger and the basolat-
eral Na,K-ATPase of all cells of the nephron [70]
and closely regulates the renin^angiotensin^aldoste-
rone system that is crucial to the maintenance of
intravascular and extracellular £uid volume. Addi-
tionally, a study on perfused rat kidneys showed
that speci¢c inhibition of NOS caused a large drop
in the fractional reabsorption of sodium, glucose and
water, and a slight increase in albumin excretion [29],
indicating a speci¢c tubular physiological e¡ect of
NO.
If it is established that the production, stability
and action of NO gradually decreases with aging,
this altered regulation of NO metabolism may be
partly due to the direct or indirect e¡ects of increased
amounts of APs and AGEs. Hence, impaired nitric
oxide synthase activity may in£uence the develop-
ment of nephropathy associated with aging and dia-
betes.
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